Healthcare Jan 07, 2021 04:13 PM (GMT+8) · EqualOcean
On January 7, EUROHEALTH signed a strategic cooperation agreement with tianguangshi. The two sides will make full use of their resource advantages and professional advantages to deepen cooperation in the development of solid tumor drug-related target diagnostic kits and tumor drug research and development. In this cooperation, Qiuzhen medicine will provide technical services and experience related to gene testing in target screening, bioinformatics data mining of tumor panel, data interpretation, central laboratory testing, and assisting in subject recruitment / enrollment; tianguangshi will provide comprehensive support in synchronous clinical testing, and cooperating with registration and declaration of accompanying diagnostic reagents.